Compare UL & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UL | BSX |
|---|---|---|
| Founded | 1930 | 1979 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.0B | 137.8B |
| IPO Year | N/A | 1992 |
| Metric | UL | BSX |
|---|---|---|
| Price | $64.36 | $88.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $125.88 |
| AVG Volume (30 Days) | 2.1M | ★ 9.0M |
| Earning Date | 07-31-2025 | 02-04-2026 |
| Dividend Yield | ★ 3.53% | N/A |
| EPS Growth | N/A | ★ 54.68 |
| EPS | ★ 3.32 | 1.87 |
| Revenue | ★ $70,194,950,090.00 | $19,349,000,000.00 |
| Revenue This Year | N/A | $21.05 |
| Revenue Next Year | N/A | $11.44 |
| P/E Ratio | ★ $19.33 | $48.15 |
| Revenue Growth | N/A | ★ 21.61 |
| 52 Week Low | $61.11 | $85.98 |
| 52 Week High | $73.87 | $109.50 |
| Indicator | UL | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 52.09 | 27.89 |
| Support Level | $61.78 | $87.22 |
| Resistance Level | $65.36 | $100.90 |
| Average True Range (ATR) | 0.64 | 1.91 |
| MACD | -0.18 | -0.71 |
| Stochastic Oscillator | 61.31 | 8.69 |
Unilever is a diversified beauty, wellbeing, and personal care (44% of 2024 sales by value), homecare (20%), and packaged food (36%) company. Its brands include Dove personal-care products, Knorr soups and sauces, Hellmann's mayonnaise, Axe and Rexona deodorants, and TRESemmé haircare. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, and Wild deodorants. The company derives 58% of its sales from emerging markets and 42% from developed markets. The US is its largest market, accounting for around 20% of sales, followed by India, which accounts for 11% of sales.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.